About Peter Olagunju
Form D filings for Cage Pharmaceuticals in 2024 list Peter Olagunju as chief executive officer and director.
Peter Olagunju first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Olagunju in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Olagunju works with at each company, as listed on that company's latest Form D.
Cage Pharmaceuticals, Inc. · Form D, May 31, 2024